BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29911923)

  • 81. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
    Chiang CL; Goswami S; Frissora FW; Xie Z; Yan PS; Bundschuh R; Walker LA; Huang X; Mani R; Mo XM; Baskar S; Rader C; Phelps MA; Marcucci G; Byrd JC; Lee LJ; Muthusamy N
    Blood; 2019 Aug; 134(5):432-444. PubMed ID: 31151986
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia.
    Hosseini-Valiki F; Taghiloo S; Tavakolian G; Amjadi O; Tehrani M; Hedayatizadeh-Omran A; Alizadeh-Navaei R; Zaboli E; Shekarriz R; Asgarian-Omran H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2615-2621. PubMed ID: 32986360
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A 3' tRNA-derived fragment produced by tRNA
    Katsaraki K; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Eur J Haematol; 2021 Jun; 106(6):821-830. PubMed ID: 33660275
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia.
    Li P; Grgurevic S; Liu Z; Harris D; Rozovski U; Calin GA; Keating MJ; Estrov Z
    PLoS One; 2013; 8(6):e64678. PubMed ID: 23750211
    [TBL] [Abstract][Full Text] [Related]  

  • 85. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.
    Mraz M; Chen L; Rassenti LZ; Ghia EM; Li H; Jepsen K; Smith EN; Messer K; Frazer KA; Kipps TJ
    Blood; 2014 Jul; 124(1):84-95. PubMed ID: 24787006
    [TBL] [Abstract][Full Text] [Related]  

  • 86. miR-197, miR-26a and miR-27a analysis in chronic lymphocytic leukemia.
    C Andrade A; Freitas TR; Dornelas GG; Gomes LC; Barbosa BL; Araújo SS; Gomes KB; Sabino AP
    Biomark Med; 2022 Aug; 16(12):903-914. PubMed ID: 35833845
    [No Abstract]   [Full Text] [Related]  

  • 87.
    Balatti V; Tomasello L; Rassenti LZ; Veneziano D; Nigita G; Wang HY; Thorson JA; Kipps TJ; Pekarsky Y; Croce CM
    Blood; 2018 Nov; 132(20):2179-2182. PubMed ID: 30242085
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of mir-92a-3p on hydroquinone induced changes in human lymphoblastoid cell cycle and apoptosis.
    Xuan M; Wu Y; Wang H; Ye Z; Wu H; Chen Y; Yang H; Tang H
    Environ Toxicol; 2023 Jun; 38(6):1420-1430. PubMed ID: 36988267
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.
    Queirós AC; Villamor N; Clot G; Martinez-Trillos A; Kulis M; Navarro A; Penas EM; Jayne S; Majid A; Richter J; Bergmann AK; Kolarova J; Royo C; Russiñol N; Castellano G; Pinyol M; Bea S; Salaverria I; López-Guerra M; Colomer D; Aymerich M; Rozman M; Delgado J; Giné E; González-Díaz M; Puente XS; Siebert R; Dyer MJ; López-Otín C; Rozman C; Campo E; López-Guillermo A; Martín-Subero JI
    Leukemia; 2015 Mar; 29(3):598-605. PubMed ID: 25151957
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.
    Rozovski U; Calin GA; Setoyama T; D'Abundo L; Harris DM; Li P; Liu Z; Grgurevic S; Ferrajoli A; Faderl S; Burger JA; O'Brien S; Wierda WG; Keating MJ; Estrov Z
    Mol Cancer; 2013 Jun; 12():50. PubMed ID: 23725032
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression.
    Sharifi M; Salehi R; Gheisari Y; Kazemi M
    Mol Biol Rep; 2014 May; 41(5):2799-808. PubMed ID: 24481878
    [TBL] [Abstract][Full Text] [Related]  

  • 92. MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27.
    Frenquelli M; Muzio M; Scielzo C; Fazi C; Scarfò L; Rossi C; Ferrari G; Ghia P; Caligaris-Cappio F
    Blood; 2010 May; 115(19):3949-59. PubMed ID: 20203269
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic Leukemia Patients.
    Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case-control study.
    Davari N; Ahmadpour F; Kiani AA; Azadpour M; Asadi ZT
    BMC Res Notes; 2021 Jan; 14(1):21. PubMed ID: 33430952
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.
    Guinn D; Lehman A; Fabian C; Yu L; Maddocks K; Andritsos LA; Jones JA; Flynn JM; Jaglowski SM; Woyach JA; Byrd JC; Johnson AJ
    Cancer Med; 2017 Apr; 6(4):778-787. PubMed ID: 28299881
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Van Roosbroeck K; Calin GA
    Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
    [TBL] [Abstract][Full Text] [Related]  

  • 97. MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients.
    Rashed RA; Hassan NM; Hussein MM
    Leuk Lymphoma; 2020 Oct; 61(10):2475-2481. PubMed ID: 32536234
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
    Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
    Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The involvement of microRNA in the pathogenesis of Richter syndrome.
    Van Roosbroeck K; Bayraktar R; Calin S; Bloehdorn J; Dragomir MP; Okubo K; Bertilaccio MTS; Zupo S; You MJ; Gaidano G; Rossi D; Chen SS; Chiorazzi N; Thompson PA; Ferrajoli A; Bertoni F; Stilgenbauer S; Keating MJ; Calin GA
    Haematologica; 2019 May; 104(5):1004-1015. PubMed ID: 30409799
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    Su XY; Zhao Q; Ke JM; Wu DH; Zhu X; Lin J; Deng ZQ
    Cancer Manag Res; 2020; 12():11871-11881. PubMed ID: 33239917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.